Stock Events

Stock Events

Painchek 

A$0.067000
4
-A$0.01-14.1%Sunday 23:25

Statistics

Day High
0.07
Day Low
0.067
52W High
0.49
52W Low
0.065
Volume
30,575
Avg. Volume
153,181
Mkt Cap
14M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Aug 28Expected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.02
0.31
0.65
0.98
Expected EPS
N/A
Actual EPS
N/A

Financials

-238.78%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.74MRevenue
-8.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PCK.AU. It's not an investment recommendation.
BetaShares NASDAQ 100
2
NDQ.AU
BlackRock Australia iShares S&P 500
2
IVV.AU
PLS Group
2
PLS.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers medical devices for pain management, directly competing in the healthcare technology space similar to Painchek's pain assessment tools.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories provides a range of medical devices and healthcare solutions, including pain management technologies that rival Painchek's offerings.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation develops and manufactures medical devices used in various healthcare conditions, including pain management solutions that compete with Painchek's technology.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical technologies, including pain management devices, making it a competitor to Painchek in the medical device market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson offers a broad range of healthcare products, including pain management solutions through its medical devices segment, competing with Painchek.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products, including solutions for pain, which competes with Painchek's pain assessment and management tools.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences Corporation focuses on patient-focused medical innovations for structural heart disease and critical care monitoring, competing in the broader healthcare technology space with Painchek.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing with Painchek by advancing minimally invasive surgery, potentially reducing postoperative pain.

About

PainChek Limited specializes in the creation and commercialization of mobile medical applications designed for individual pain assessment. Their core product, PainChek, employs smartphone and tablet cameras to record video, which is then analyzed in real-time by facial recognition software to detect the presence of pain. This technology is particularly beneficial for patients suffering from dementia. The company, which operates from its headquarters in Sydney, Australia, rebranded as PainChek Limited in January 2018, having previously been known as ePAT Technologies Ltd.
Show More
CEO
Karen Holzberger
Employees
25
Country
Australia
ISIN
AU000000PCK6

Listings

AU
AU
PCK.AU

0 Comments

Share your thoughts

FAQs

What is Painchek stock price today?▼
The current price of PCK.AU is A$0.07 AUD — it has decreased by -14.1% in the past 24 hours. Watch Painchek stock price performance more closely on the chart.
What is Painchek stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Painchek stocks are traded under the ticker PCK.AU.
Is Painchek stock price growing?▼
PCK.AU stock has fallen by -8.22% compared to the previous week, the month change is a -30.21% fall, over the last year Painchek has showed a -86.04% decrease.
What is Painchek market cap?▼
Today Painchek has the market capitalization of 14M
When is the next Painchek earnings date?▼
Painchek is going to release the next earnings report on March 3, 2027.
What is Painchek revenue for the last year?▼
Painchek revenue for the last year amounts to 3.74M AUD.
What is Painchek net income for the last year?▼
PCK.AU net income for the last year is -8.94M AUD.
How many employees does Painchek have?▼
As of November 2, 2026, the company has 25 employees.
In which sector is Painchek located?▼
Painchek operates in the Health & Wellness sector.
When did Painchek complete a stock split?▼
The last stock split for Painchek was on November 28, 2025 with a ratio of 1:10.
Where is Painchek headquartered?▼
Painchek is headquartered in Sydney, Australia.